Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-18T11:12:46.519Z Has data issue: false hasContentIssue false

The haemodilution enhanced onset of coagulation as measured by the thrombelastogram is transient

Published online by Cambridge University Press:  01 March 2006

T. G. Ruttmann
Affiliation:
Stanford University, Department of Anesthesiology, CA, USA
H. J. M. Lemmens
Affiliation:
Stanford University, Department of Anesthesiology, CA, USA
K. A. Malott
Affiliation:
Stanford University, Department of Anesthesiology, CA, USA
J. G. Brock-Utne
Affiliation:
Stanford University, Department of Anesthesiology, CA, USA
Get access

Extract

Summary

Background and objective: Crystalloid haemodilution has been widely found to enhance coagulation onset, but the duration of this effect has never been documented. Methods: Twelve healthy, consenting volunteers had a rapid infusion of 14 mL kg−1 of normal (0.9%) saline. Blood samples were taken, prior to (control), and immediately after (30 min) the rapid saline infusion was completed (30 min). They were then repeated at regular intervals up to 120 min. Haematocrit/platelet counts were taken to determine the degree of dilution and thrombelastograms, with and without platelet antagonists (ReoPro, Abciximab), were measured in all samples. Antithrombin levels were selectively measured. Results: The haematocrit and platelet count showed a rapid dilutional decrease at 30 min (mean of −12.2% and −14.4%, respectively), with values returning towards baseline within 15 min after finishing the infusion. There was a significantly faster onset of coagulation (decrease in r-time) in the post-infusion sample (30 min) compared to control (P < 0.05), again returning towards normal as the dilution effect was reversed. Similar thrombelastograms findings were evident in the plasma factor only group (platelets inhibited by ReoPro). Antithrombin levels changed in keeping with the haemodilution effect (P < 0.0001). There was a linear relationship between antithrombin and thrombelastograms r-time (P = 0.012). Conclusion: The faster onset of coagulation brought on by haemodilution return towards normal as the dilutional effect is reversed. This effect is mediated through plasma clotting factors. Of interest is the significant inverse correlation of the onset of coagulation increasing as the antithrombin levels decreased with dilution.

Type
Original Article
Copyright
© 2006 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gibbs NM, Crawford GP, Michalopoulos N. Thrombelastographic patterns following abdominal aortic surgery. Anaesth Intensive Care 1994; 22: 534538.Google Scholar
Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. The effect of potato starch derived and corn starch derived hydroxyethyl starch on in vitro blood coagulation. Anaesthesia 1998; 53: 638644.Google Scholar
McCammon AT, Wright JP, Figueroa M, Nielsen VG. Hemodilution with albumin, but not Hextend, results in hypercoagulability as assessed by thrombelastography in rabbits: role of heparin-dependent serpins and factor VIII complex. Anesth Analg 2002; 95: 844850 (Table).Google Scholar
Ng KF, Lo JW. The development of hypercoagulability state, as measured by thrombelastography, associated with intraoperative surgical blood loss. Anaesth Intensive Care 1996; 24: 2025.Google Scholar
Ng KF, Lam CC, Chan LC. In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth 2002; 88: 475480.Google Scholar
Ruttmann TG, James MF, Viljoen JF. Haemodilution induces a hypercoagulable state. Br J Anaesth 1996; 76: 412414.Google Scholar
Ruttmann TG, James MF, Aronson I. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998; 80: 612616.Google Scholar
Ruttmann TG, James MF, Finlayson J. Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery. Br J Anaesth 2002; 89: 226230.Google Scholar
Tuman KJ, Spiess BD, McCarthy RJ, Ivankovich AD. Effects of progressive blood loss on coagulation as measured by thrombelastography. Anesth Analg 1987; 66: 856863.Google Scholar
Whalen J, Tuman KJ. Monitoring hemostasis. Int Anesthesiol Clin 1996; 34: 195213.Google Scholar
Tocantins LM, Carroll RT, Holburn RH. The clot accelerating effect of dilution on blood and plasma. Relation to the mechanism of coagulation of normal and hemophilic blood. Blood 1951; 6: 720739.Google Scholar
Monkhouse FC. Relationship between antithrombin and thrombin levels in plasma and serum. Am J Physiol 1959; 197: 984988.Google Scholar
Janvrin SB, Davies G, Greenhalgh RM. Postoperative deep vein thrombosis caused by intravenous fluids during surgery. Br J Surg 1980; 67: 690693.Google Scholar
Ruttmann TG. Haemodilution enhances coagulation. Br J Anaesth 2002; 88: 470472.Google Scholar
Ruttmann TG, Jamest MF, Lombard EH. Haemodilution-induced enhancement of coagulation is attenuated in vitro by restoring antithrombin III to pre-dilution concentrations. Anaesth Intensive Care 2001; 29: 489493.Google Scholar
Bellitti P, Valeriano R, Gasperi M, Sodini L, Barletta D. Cortisol and heart rate changes in first- and fourth-time donors. Vox Sang 1994; 67: 4245.Google Scholar
Ruttmann TG, Roche AM, Gasson J, James MF. The effects of a one unit blood donation on autohaemo-dilution and coagulation. Anaesth Intensive Care 2003; 31: 4043.Google Scholar
Griffith MJ. Kinetic analysis of the heparin-enhanced antithrombin III/thrombin reaction. Reaction rate enhancement by heparin-thrombin association. J Biol Chem 1979; 254: 12 04412 049.Google Scholar
Jesty J, Beltrami E, Willems G. Mathematical analysis of a proteolytic positive-feedback loop: dependence of lag time and enzyme yields on the initial conditions and kinetic parameters. Biochemistry 1993; 32: 62666274.Google Scholar
Nossel HL, Yudelman I, Canfield RE, Butler Jr VP, Spanodis K, Wilner GD, Qureshi GD. Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 4353.Google Scholar
Nossel HL. Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis. N Engl J Med 1976; 295: 428432.Google Scholar
Jesty J. The kinetics of inhibition of thrombin by antithrombin in the presence of components of the hemostatic system. Blood 1985; 66: 11891195.Google Scholar
Jesty J. The kinetics of inhibition of alpha-thrombin in human plasma. J Biol Chem 1986; 261: 10 313–10 318.Google Scholar
Jesty J. Measurement of the kinetics of inhibition of activated coagulation factor X in human plasma: the effect of plasma and inhibitor concentration. Anal Biochem 1986; 152: 402411.Google Scholar
Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 64906505.Google Scholar
Downing MR, Bloom JW, Mann KG. Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry 1978; 17: 26492653.Google Scholar